Prognostic factors in human colorectal cancer.
Bianco
A R
AR
Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Facoltà di Medicina e Chirurgia, Università degli Studi Federico II, Napoli, Italy.
Carlomagno
C
C
De Laurentiis
M
M
De Placido
S
S
Tortora
G
G
Ciardiello
F
F
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D002455:Cell Division; D015179:Colorectal Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology* / Q000401:mortality / Q000473:pathology; D004273:DNA, Neoplasm / Q000032:analysis; D005472:Fluorouracil / Q000627:therapeutic use; D016147:Genes, Tumor Suppressor / Q000235:genetics; D006801:Humans; D009154:Mutation; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic; D011379:Prognosis; D011519:Proto-Oncogenes / Q000235:genetics; D012307:Risk Factors; D015996:Survival Rate; D013940:Thymidylate Synthase / Q000187:drug effects
D000964:Antimetabolites, Antineoplastic; D004273:DNA, Neoplasm; D013940:Thymidylate Synthase; D005472:Fluorouracil